Relationship between doses to anatomical structures and erectile dysfunction after radiotherapy for prostate cancer: A systematic review
CONCLUSION: We currently have little data to show a correlation between erectile dysfunction and sexual structures. It would be necessary to have additional prospective studies evaluating the impact of an optimization on these sexual structures on erectile dysfunction.PMID:37596125 | DOI:10.1016/j.canrad.2023.07.010 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - August 18, 2023 Category: Cancer & Oncology Authors: A Ailloud C Udrescu S Horn C Enachescu G Cr éhange P Sargos S Supiot T Zilli A Lapierre O Chapet Source Type: research
Radiotherapy of rare head and neck tumors
We present here a review of the literature and available guidelines for the management by radiotherapy of rare upper aerodigestive tract tumors.PMID:37596121 | DOI:10.1016/j.canrad.2023.06.020 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - August 18, 2023 Category: Cancer & Oncology Authors: L Sauvage V Calugaru G Janoray Source Type: research
Clinical research in private sector: Which strategic analysis?
Cancer Radiother. 2023 Aug 16:S1278-3218(23)00137-3. doi: 10.1016/j.canrad.2023.06.023. Online ahead of print.ABSTRACTClinical research in private practice has significantly increased in recent years and has become crucial for the attractiveness of centres both for patients who can access innovative treatments and molecules and for participating physicians. The responsiveness, the size and reduced number of interlocutors, flexibility, and decision-making autonomy of private practitioners are strengths in the strategic analysis of clinical research in the private sector. However, the varied medical activity allowing for bro...
Source: Cancer Radiotherapie - August 18, 2023 Category: Cancer & Oncology Authors: A Ruffier Y Pointreau V Sacier M Balavoine A Lamrani-Ghaouti S Guihard S Rivera Source Type: research
Radiation-induced pulmonary fibrosis: New potential targets
Cancer Radiother. 2023 Aug 16:S1278-3218(23)00141-5. doi: 10.1016/j.canrad.2023.06.026. Online ahead of print.ABSTRACTRadiation-induced pulmonary fibrosis (RIPF) is one of the major and late complications of radiotherapy (RT) with an average incidence rate between 16 and 28% after RT. RIPF significantly affects the function of the affected tissues/organs as well as the quality of life and survival of patients. The process of radiation fibrogenesis is initiated by a very complex signaling network that involves several cellular and molecular factors and the development of effective treatments relies on a better understanding...
Source: Cancer Radiotherapie - August 18, 2023 Category: Cancer & Oncology Authors: E Deutsch L Meziani Source Type: research
Radiation therapists shortage in France: Organizational consequences and difficulties in deploying new missions and/or tasks delegation
CONCLUSION: This survey shows a significant impact of radiation therapist shortage in radiotherapy oncology care (treatment delays, access to caregiver support time, workload on treatment teams), and represents a major obstacle to the development of radiotherapy structures.PMID:37596123 | DOI:10.1016/j.canrad.2023.07.007 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - August 18, 2023 Category: Cancer & Oncology Authors: C Bourgier S Boisbouvier É Bayart J Chamois P Clav ère S Corbin A De Oliveira J-M Hannoun-L évi A Hasbini C Geffroy-Hulot P Le Tallec É Monpetit J-J Santini Source Type: research
Relationship between doses to anatomical structures and erectile dysfunction after radiotherapy for prostate cancer: A systematic review
CONCLUSION: We currently have little data to show a correlation between erectile dysfunction and sexual structures. It would be necessary to have additional prospective studies evaluating the impact of an optimization on these sexual structures on erectile dysfunction.PMID:37596125 | DOI:10.1016/j.canrad.2023.07.010 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - August 18, 2023 Category: Cancer & Oncology Authors: A Ailloud C Udrescu S Horn C Enachescu G Cr éhange P Sargos S Supiot T Zilli A Lapierre O Chapet Source Type: research
Radiotherapy in the management of synchronous metastatic lung cancer
Cancer Radiother. 2023 Aug 11:S1278-3218(23)00135-X. doi: 10.1016/j.canrad.2023.03.002. Online ahead of print.ABSTRACTMetastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review t...
Source: Cancer Radiotherapie - August 13, 2023 Category: Cancer & Oncology Authors: J Khalifa A L évy L-M Sauvage S Thureau J Darr éon C Le P échoux D Lerouge N Pourel D Antoni E Blais É Martin A Marguerit P Giraud F-G Riet Source Type: research
Radiotherapy in the management of synchronous metastatic lung cancer
Cancer Radiother. 2023 Aug 11:S1278-3218(23)00135-X. doi: 10.1016/j.canrad.2023.03.002. Online ahead of print.ABSTRACTMetastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review t...
Source: Cancer Radiotherapie - August 13, 2023 Category: Cancer & Oncology Authors: J Khalifa A L évy L-M Sauvage S Thureau J Darr éon C Le P échoux D Lerouge N Pourel D Antoni E Blais É Martin A Marguerit P Giraud F-G Riet Source Type: research
Radiotherapy in the management of synchronous metastatic lung cancer
Cancer Radiother. 2023 Aug 11:S1278-3218(23)00135-X. doi: 10.1016/j.canrad.2023.03.002. Online ahead of print.ABSTRACTMetastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review t...
Source: Cancer Radiotherapie - August 13, 2023 Category: Cancer & Oncology Authors: J Khalifa A L évy L-M Sauvage S Thureau J Darr éon C Le P échoux D Lerouge N Pourel D Antoni E Blais É Martin A Marguerit P Giraud F-G Riet Source Type: research
Radiotherapy in the management of synchronous metastatic lung cancer
Cancer Radiother. 2023 Aug 11:S1278-3218(23)00135-X. doi: 10.1016/j.canrad.2023.03.002. Online ahead of print.ABSTRACTMetastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review t...
Source: Cancer Radiotherapie - August 13, 2023 Category: Cancer & Oncology Authors: J Khalifa A L évy L-M Sauvage S Thureau J Darr éon C Le P échoux D Lerouge N Pourel D Antoni E Blais É Martin A Marguerit P Giraud F-G Riet Source Type: research
Radiotherapy in the management of synchronous metastatic lung cancer
Cancer Radiother. 2023 Aug 11:S1278-3218(23)00135-X. doi: 10.1016/j.canrad.2023.03.002. Online ahead of print.ABSTRACTMetastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review t...
Source: Cancer Radiotherapie - August 13, 2023 Category: Cancer & Oncology Authors: J Khalifa A L évy L-M Sauvage S Thureau J Darr éon C Le P échoux D Lerouge N Pourel D Antoni E Blais É Martin A Marguerit P Giraud F-G Riet Source Type: research
Impact of immunotherapy on the therapeutic strategy for the management of stage I non-small cell lung cancer: The radiation oncologist's point of view
Cancer Radiother. 2023 Aug 10:S1278-3218(23)00142-7. doi: 10.1016/j.canrad.2023.06.028. Online ahead of print.ABSTRACTSurgery is the standard treatment for operable patients with stage I non-small cell lung cancer (NSCLC) (T1-T2aN0M0). Stereotactic body radiotherapy (SBRT) is the treatment of choice for non-operable patients, and its positioning for operable patients remains to be clarified. The pattern of recurrence after management of stage I NSCLC is dominated by the risk of distant recurrence, this constituting the rationale for the adjunction of systemic treatment, and especially check point inhibitor (CPI), in combin...
Source: Cancer Radiotherapie - August 12, 2023 Category: Cancer & Oncology Authors: J Khalifa Source Type: research
Clinical research in general hospital centres in France, strengths and weaknesses
Cancer Radiother. 2023 Aug 10:S1278-3218(23)00150-6. doi: 10.1016/j.canrad.2023.07.008. Online ahead of print.ABSTRACTClinical research is an essential activity in cancer care. Both for patients, who can gain access to innovative therapies, and for practitioners, who can maintain their skills and stay at the forefront of new treatment approaches. First developed in university hospitals, clinical research is now established in general hospitals and private health institutions. The number of patient inclusions in clinical trials has doubled over the last ten years, thus reflecting the dynamism of it. Strengths and weaknesses...
Source: Cancer Radiotherapie - August 12, 2023 Category: Cancer & Oncology Authors: D Argo-Leignel P Bouju M Le Saux N Leissen R Gu égan Y Pointreau Y Alexandre G Bera Source Type: research
Ethical stakes of information in radiation oncology: Thinking the risk and building the therapeutic alliance
Cancer Radiother. 2023 Aug 10:S1278-3218(23)00119-1. doi: 10.1016/j.canrad.2023.06.006. Online ahead of print.ABSTRACTInforming patients before receiving radiation therapy is a fundamental ethical imperative. As a condition of the possibility of autonomy, information allows people to make health decisions concerning themselves, which is required by French law. This information includes in particular the potential risks due to radiation therapy. It is therefore necessary to think about what risk is, and how to define and assess it, in order to finally communicate it. The practice of informing people involves many ethical is...
Source: Cancer Radiotherapie - August 12, 2023 Category: Cancer & Oncology Authors: T Haaser L Lahmi D Osman C Gesbert V Cheval Y Constantinides R de Crevoisier C Dejean A Escande Y Ghannam F Lorchel S Thureau J L Lagrange C Durdux F Huguet Commission éthique de la SFRO Source Type: research
Stereotactic radiotherapy for operable stage I non-small cell lung cancer
This article reviews the available data in the literature of the place of stereotactic body radiotherapy for medically operable patients with stage I non-small cell lung cancer.PMID:37563012 | DOI:10.1016/j.canrad.2023.07.012 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - August 10, 2023 Category: Cancer & Oncology Authors: É Martin C Nicolet P Boisselier J Khalifa S Thureau Source Type: research
